Aberdeen Group
INSP icon

Aberdeen Group’s Inspire Medical Systems INSP Stock Holding History

Aberdeen Group’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Sell
358,968
-118,508
-25% -$5.62M 0.02% 502
2026
Q1 		$24.6M Buy
477,476
+16,575
+4% +$1.16M 0.04% 360
2025
Q4 		$42.5M Buy
460,901
+64,561
+16% +$6.18M 0.07% 248
2025
Q3 		$30M Buy
396,340
+153,238
+63% +$15.5M 0.05% 313
2025
Q2 		$31.5M Buy
243,102
+121,741
+100% +$17.7M 0.05% 299
2025
Q1 		$19.3M Hold
121,361
– – 0.04% 399
2024
Q4 		$22.4M Hold
121,361
– – 0.04% 345
2024
Q3 		$25.6M Buy
121,361
+16,881
+16% +$2.93M 0.05% 334
2024
Q2 		$14M Buy
104,480
+58,519
+127% +$11.1M 0.03% 453
2024
Q1 		$9.87M Hold
45,961
– – 0.02% 548
2023
Q4 		$9.35M Buy
+45,961
New +$7.45M 0.02% 563

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Aberdeen Group's INSP Position: Q2 2026 in Review

Aberdeen Group reduced its Inspire Medical Systems (INSP) stake by 25% in Q2 2026, selling an estimated $5.62M and leaving 358,968 shares worth $16M. The position accounts for 0.02% of the portfolio, ranked #502.

Aberdeen Group first reported a position in INSP in Q4 2023 and has held it in 11 quarters since. The position peaked at $42.5M in Q4 2025. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Aberdeen Group held 358,968 shares of Inspire Medical Systems worth $16M as of Q2 2026.
  • Aberdeen Group sold 118,508 Inspire Medical Systems shares in Q2 2026, an estimated $5.62M.
  • Inspire Medical Systems made up 0.02% of Aberdeen Group's portfolio in Q2 2026, its #502 holding.
  • Aberdeen Group first reported a position in Inspire Medical Systems in Q4 2023 and has held it in 11 quarters since.
  • Aberdeen Group's Inspire Medical Systems position peaked at $42.5M in Q4 2025.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.